Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

[1]  Svetlana K. Eden,et al.  Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies* , 2009, Critical care medicine.

[2]  S. Cole,et al.  Competing risk regression models for epidemiologic data. , 2009, American journal of epidemiology.

[3]  L. Mermel,et al.  Are There Differences in Hospital Cost Between Patients With Nosocomial Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Those With Methicillin-Susceptible S. aureus Bloodstream Infection? , 2009, Infection Control & Hospital Epidemiology.

[4]  Martin Schumacher,et al.  Nosocomial Infection, Length of Stay, and Time-Dependent Bias , 2009, Infection Control & Hospital Epidemiology.

[5]  Bala N Hota,et al.  Lost in Translation? Reliability of Assessing Inpatient Antimicrobial Appropriateness With Use of Computerized Case Vignettes , 2009, Infection Control & Hospital Epidemiology.

[6]  M. Schumacher,et al.  Modeling the effect of time-dependent exposure on intensive care unit mortality , 2009, Intensive Care Medicine.

[7]  D. Maki,et al.  International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. , 2008, American journal of infection control.

[8]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[9]  M. Bergevin,et al.  Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  Martin Schumacher,et al.  Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models , 2008, Critical care.

[11]  N. Kim,et al.  Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia , 2007, Antimicrobial Agents and Chemotherapy.

[12]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[13]  P. J. Z. Teixeira,et al.  Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. , 2007, The Journal of hospital infection.

[14]  Nicholas Graves,et al.  Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost , 2007, Infection Control & Hospital Epidemiology.

[15]  L. Szczech,et al.  Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Turchi,et al.  Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. , 2006, The Journal of hospital infection.

[17]  Tim E A Peto,et al.  Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study , 2006, BMJ : British Medical Journal.

[18]  S. Chevret,et al.  Evaluating mortality in intensive care units: contribution of competing risks analyses , 2005, Critical care.

[19]  I. Gould,et al.  The clinical significance of methicillin-resistant Staphylococcus aureus. , 2005, The Journal of hospital infection.

[20]  Y. Carmeli,et al.  The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance , 2005, Infection Control & Hospital Epidemiology.

[21]  Y. Carmeli,et al.  Impact of Severity of Illness Bias and Control Group Misclassification Bias in Case-Control Studies of Antimicrobial-Resistant Organisms , 2005, Infection Control & Hospital Epidemiology.

[22]  S. Cosgrove,et al.  The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.

[23]  Anirban Basu,et al.  Comparing alternative models: log vs Cox proportional hazard? , 2004, Health economics.

[24]  H. Bruining,et al.  Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. , 2003, The European journal of surgery = Acta chirurgica.

[25]  W. Gransden,et al.  Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Stephan Harbarth,et al.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. , 2003, The American journal of medicine.

[27]  D. G. Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[28]  The Cost of Antibiotic Resistance: Effect of Resistance Among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on Length of Hospital Stay , 2002, Infection Control & Hospital Epidemiology.

[29]  J. Verhoef,et al.  Frequency of Isolation and Antimicrobial Resistance of Gram-Negative and Gram-Positive Bacteria from Patients in Intensive Care Units of 25 European University Hospitals Participating in the European Arm of the SENTRY Antimicrobial Surveillance Program 1997–1998 , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[30]  J. Mylotte,et al.  Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Whitby,et al.  Nosocomial Methicillin-Resistant Staphylococcus aureus Bacteremia: Is It Any Worse Than Nosocomial Methicillin-Sensitive Staphylococcus aureus Bacteremia? , 2000, Infection Control & Hospital Epidemiology.

[32]  M. Roghmann.  Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. , 2000, Archives of internal medicine.

[33]  Á. Soriano,et al.  Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[35]  D. Sexton,et al.  Nosocomial Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus Primary Bacteremia: At What Costs? , 1999, Infection Control & Hospital Epidemiology.

[36]  D. Pittet,et al.  Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. , 1998, Archives of internal medicine.

[37]  M Schumacher,et al.  Efficient Risk Set Sampling when a Time-dependent Exposure Is Present , 2009, Methods of Information in Medicine.

[38]  T. Adam,et al.  Cost Effectiveness and Resource Allocation Econometric Estimation of Country-specific Hospital Costs , 2003 .

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.